Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Cornu

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Orphanet Journal of Rare Diseases|March 17, 2015
A methodological framework for drug development in rare diseasesPatrice Nony, Polina Kurbatova, Agathe Bajard, et al.
BMC Complementary and Alternative Medicine|June 24, 2010
A dietary supplement to improve the quality of sleep: a randomized placebo controlled trialCatherine Cornu, Laurent Remontet, Florence Noel-Baron, et al.
British Journal of Clinical Pharmacology|March 18, 2010
No effect of a homoeopathic combination of Arnica montana and Bryonia alba on bleeding, inflammation, and ischaemia after aortic valve surgeryCatherine Cornu, Pierre Joseph, Ségolène Gaillard, et al.
Diabetologia|August 4, 2022
SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefitsElisa Marilly, Judith Cottin, Natalia Cabrera, et al.
Fundamental & Clinical Pharmacology|December 31, 2016
Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta-analysis: GLUCOSE DINET protocol-Rational and designGuillaume Grenet, Audrey Lajoinie, Shams Ribault, et al.
Journal of Clinical Epidemiology|July 19, 2015
An in silico approach helped to identify the best experimental design, population, and outcome for future randomized clinical trialsAgathe Bajard, Sylvie Chabaud, Catherine Cornu, et al.
Plos Medicine|April 18, 2012
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trialsRémy Boussageon, Irène Supper, Theodora Bejan-Angoulvant, et al.
Pediatrics|February 19, 2014
Ophthalmic outcomes of congenital toxoplasmosis followed until adolescenceMartine Wallon, Justus G Garweg, Michal Abrahamowicz, et al.
Therapie|April 9, 2017
[Good professional practices of French CICs - version # 2]Hugues Chevassus, Charlène Duchesne, Annabelle Sailly, et al.
BMJ (Clinical Research Ed.)|July 28, 2011
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsRémy Boussageon, Theodora Bejan-Angoulvant, Mitra Saadatian-Elahi, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Orphanet Journal of Rare Diseases|March 17, 2015
A methodological framework for drug development in rare diseasesPatrice Nony, Polina Kurbatova, Agathe Bajard, et al.
BMC Complementary and Alternative Medicine|June 24, 2010
A dietary supplement to improve the quality of sleep: a randomized placebo controlled trialCatherine Cornu, Laurent Remontet, Florence Noel-Baron, et al.
British Journal of Clinical Pharmacology|March 18, 2010
No effect of a homoeopathic combination of Arnica montana and Bryonia alba on bleeding, inflammation, and ischaemia after aortic valve surgeryCatherine Cornu, Pierre Joseph, Ségolène Gaillard, et al.
Diabetologia|August 4, 2022
SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefitsElisa Marilly, Judith Cottin, Natalia Cabrera, et al.
Fundamental & Clinical Pharmacology|December 31, 2016
Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta-analysis: GLUCOSE DINET protocol-Rational and designGuillaume Grenet, Audrey Lajoinie, Shams Ribault, et al.
Journal of Clinical Epidemiology|July 19, 2015
An in silico approach helped to identify the best experimental design, population, and outcome for future randomized clinical trialsAgathe Bajard, Sylvie Chabaud, Catherine Cornu, et al.
Plos Medicine|April 18, 2012
Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trialsRémy Boussageon, Irène Supper, Theodora Bejan-Angoulvant, et al.
Pediatrics|February 19, 2014
Ophthalmic outcomes of congenital toxoplasmosis followed until adolescenceMartine Wallon, Justus G Garweg, Michal Abrahamowicz, et al.
Therapie|April 9, 2017
[Good professional practices of French CICs - version # 2]Hugues Chevassus, Charlène Duchesne, Annabelle Sailly, et al.
BMJ (Clinical Research Ed.)|July 28, 2011
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsRémy Boussageon, Theodora Bejan-Angoulvant, Mitra Saadatian-Elahi, et al.
Pageof 9